RESOURCES


home.aspx
   
How big pharma and startups can learn from each other HOW BIG PHARMA AND STARTUPS CAN LEARN FROM EACH OTHER

article

Nov 15, 2019

The way to accelerate benefit to patients changes over time as technology improves and innovation becomes more cutting edge. I’ve always looked for the more cutting-edge projects because, quite frankly, they’re just more intellectually stimulating for me. I like being on the vanguard whe...

Read More

The market for unborn children: Big Pharma, vaccines and trafficking of aborted fetuses THE MARKET FOR UNBORN CHILDREN: BIG PHARMA, VACCINES AND TRAFFICKING OF ABORTED FETUSES

article

Oct 01, 2019

American family clinics, such as the Planned Parenthood Institute, first help women stop pregnancy . And immediately after, with half-closed doors, a very profitable journey begins. The aborted fetus is dissected in different parts, liver, kidney, thyme, skin, which are sold. A liver can cost up to ...

Read More

Pharma Ecommerce: What It Takes To Win Online PHARMA ECOMMERCE: WHAT IT TAKES TO WIN ONLINE

article

Sep 17, 2019

The pharma ecommerce question doesn’t end with distributors. In fact, pharma manufacturers, too, must carve out a place in the digital ecosystem. So what can pharmaceutical manufacturers do to improve their customer experience through ecommerce? The article brought up a lot of great points, bu...

Read More

Four stand-out skills you need to move into the pharma industry FOUR STAND-OUT SKILLS YOU NEED TO MOVE INTO THE PHARMA INDUSTRY

article

Sep 16, 2019

The pharmaceutical industry is an exciting, fast-paced and ever-changing world to work in. I talk to pharmaceutical sales professionals daily, from Graduate Sales Representatives promoting ‘me too’ drugs, to Senior Sales Directors working on specialist rare disease products, and have a s...

Read More

Your Cancer Targets May Not Be Real YOUR CANCER TARGETS MAY NOT BE REAL

article

Sep 12, 2019

A paper from Cold Spring Harbor labs that invalidated MELK as a cancer target. That was straightforward enough: knocking it out via CRISPR across a whole range of cancer cell lines had no effect on their growth at all, so it’s kind of hard to make the case that it’s an important thing to...

Read More

Valuation of Pharma Companies: 5 Key Considerations VALUATION OF PHARMA COMPANIES: 5 KEY CONSIDERATIONS

article

Sep 10, 2019

Valuing pharma companies isn’t the same as valuing non-pharma companies, for several reasons. The life cycle of prescription drugs is relatively brief, with high-margin revenue falling to zero almost overnight when drug patents expire. Pharmaceuticals are high-growth, high-profit, and high-ris...

Read More

The Future Of Pharma: Harnessing AI To Decentralise Data THE FUTURE OF PHARMA: HARNESSING AI TO DECENTRALISE DATA

article

Sep 09, 2019

Most tools and technologies that do advanced analytics or search, especially in pharma, force you to build a common repository for the data before any analytics can begin. This means one must invest in building something like a data warehouse or data lake first, then add your analytics engine on top...

Read More

5 Steps to Social Media Strategy for Pharma 5 STEPS TO SOCIAL MEDIA STRATEGY FOR PHARMA

article

Sep 05, 2019

With almost 2.7 billion social media users worldwide it is vital that pharmaceutical companies form a social media strategy. Social media has transformed the way both consumers and companies communicate and has become the norm across other industries creating an expectation for consumers and patient...

Read More

Deal Or No Deal: How Brexit Is Impacting Pharma DEAL OR NO DEAL: HOW BREXIT IS IMPACTING PHARMA

article

Aug 30, 2019

At the time of writing, the United Kingdom (UK) is on its third deadline to leave the European Union (EU). What was deemed to be “the easiest trade deal in human history1” is now looking ever increasingly unlikely; and is beginning to cause anguish for not only the pharmaceutical industr...

Read More

The promise and pitfalls of molecular testing in oncology THE PROMISE AND PITFALLS OF MOLECULAR TESTING IN ONCOLOGY

article

Aug 30, 2019

Great strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain that frustrate both physicians and patients. Central to this is how to use the large amounts of genetic data now available. Dr Chris Gaj explores the challenges and potential consequences f...

Read More

Real World Evidence: A Pharma-evolution REAL WORLD EVIDENCE: A PHARMA-EVOLUTION

article

Aug 28, 2019

Smart devices and wearables are the norm of the day. We wake up in the morning to our watch reminding us of the number of steps to walk, the speed of our heart beats etc. The same watch vibrates if we are stationary at our work station, prompting us to move. There is a surge in health-related data g...

Read More

Top Things to Consider Before Investing in Pharma Machinery TOP THINGS TO CONSIDER BEFORE INVESTING IN PHARMA MACHINERY

article

Aug 26, 2019

Investment in pharma machinery requires lots of finance and efforts. Hence, the process needs to be very careful and considerate. There are numerous options in terms of make and models. Choosing the right one is difficult whether you buy a first-hand or a used machine. This post helps you to select ...

Read More

Why a no-deal Brexit means more fake pharma WHY A NO-DEAL BREXIT MEANS MORE FAKE PHARMA

article

Aug 21, 2019

Medicines are the most common medical intervention used across the UK and Europe. Unfortunately, falsified or fake medicines are entering global supply chains and have become a leading public health concern worldwide. It is, therefore, vital that there are systems in place to stop the manufacturing ...

Read More

FDA Sent These Warning Letters To Pharma/Device Companies FDA SENT THESE WARNING LETTERS TO PHARMA/DEVICE COMPANIES

article

Aug 20, 2019

We cover three drug warning letters, one issued to a compounding pharmacy, one device warning letter and one in the food area that is a ‘first of its kind’. One of the drug warning letters is issued to a firm that recovered solvents that were used in the manufacture of the API of valsart...

Read More

5 POTENTIAL IMPACTS THE PHARMA INDUSTRY SHOULD BE PLANNING FOR 5 POTENTIAL IMPACTS THE PHARMA INDUSTRY SHOULD BE PLANNING FOR

article

Aug 19, 2019

The Pharmaceutical industry has an annual turnover of 41.8 billion pounds, providing 8.2 Percent of UK goods exported and collectively employing 113,000 people, and is thus a major contributor to the nations ability to care for an ageing population and support an uncertain economy. What challenges d...

Read More

Understanding and Removing the Barriers to Patient Retention UNDERSTANDING AND REMOVING THE BARRIERS TO PATIENT RETENTION

article

Aug 14, 2019

Each year, 1.89 billion dollars is spent on patient recruitment for clinical trials.1 With a 30 Percent average dropout rate across all clinical trials, many pharmaceutical companies are spending a large amount of money to recruit patients who arent staying enrolled in their trials.

Read More

Authorized Generics Explained AUTHORIZED GENERICS EXPLAINED

article

Aug 13, 2019

DRUGMAKERS LATEST GAMBIT EXPLAINED: DESIGNED TO EXTEND MARKET EXCLUSIVITY AND STIFLE OR DELAY COMPETITION, AUTHORIZED GENERICS CAN BE MORE PROFITABLE THAN BRAND. In 1984, the Hatch-Waxman Act established the modern generic drug business by establishing rules for safety and competition, including gra...

Read More

Adoption of closed loop medicines administration into the NHS ADOPTION OF CLOSED LOOP MEDICINES ADMINISTRATION INTO THE NHS

article

Aug 08, 2019

Closed loop medicines administration (CLMA) is the functionality that supports the cross checking of the correct patient, medicine and prescription using digital technologies. Specifically, checking should be used to confirm the patient identity against the medicine/dose due and the actual medicine ...

Read More

Six ways to survive working as an on-call pharmacist SIX WAYS TO SURVIVE WORKING AS AN ON-CALL PHARMACIST

article

Aug 08, 2019

Working on call could be one of the most stressful parts of a pharmacists career, but it is also an essential part of a junior pharmacists training and a time during which you can learn the most. Clinical learning is at the forefront of most junior pharmacists minds, but it is the operational learni...

Read More

What is the future of Continuing Medical Education CME? WHAT IS THE FUTURE OF CONTINUING MEDICAL EDUCATION CME?

article

Aug 07, 2019

In today’s knowledge-based society, health care professionals (HCPs) have a responsibility to continuously develop and refine their skills through lifelong learning. Academic institutes can foster such learning through programmes of continuing medical education (CME). But what is CME and why i...

Read More

How can technology improve the narrative for pharma? HOW CAN TECHNOLOGY IMPROVE THE NARRATIVE FOR PHARMA?

article

Aug 07, 2019

The pharmaceutical and healthcare industries in the UK and across the world are facing a multitude of challenges. They are being challenged on how they differentiate themselves in a growing and crowded marketplace, how they engage with their audiences and how they remain innovative and relevant.

Read More

Future of Pharma: Building the Right Environment for AI Success FUTURE OF PHARMA: BUILDING THE RIGHT ENVIRONMENT FOR AI SUCCESS

article

Jul 25, 2019

What does the future of pharma look like through the eyes of a technologists background? We were fortunate enough to find out at last month at our 2nd annual GNS Forum. Shahram Ebadollahi, PhD, MBA who is the Global Head of Data Science and AI at Novartis AG, joined us to share his thoughts on how t...

Read More

Pharmalittle: New records show drug makers opioid push PHARMALITTLE: NEW RECORDS SHOW DRUG MAKERS OPIOID PUSH

article

Jul 24, 2019

Rise and shine, everyone, the middle of the week is already here. And a hazy, muggy morning is unfolding here on the Pharmalot campus this morning, where the officials mascot is noisily snoozing and one of the short people is sleeping in. As for us, we are downing yet another needed cup of stimulati...

Read More

Google AI Could Challenge Big Pharma in Drug Discovery GOOGLE AI COULD CHALLENGE BIG PHARMA IN DRUG DISCOVERY

article

Jul 21, 2019

A win for DeepMind, the AI arm of Google’s parent Alphabet, at a biennial biology conference could upend how drugmakers find and develop new medicines, according to Bloomberg. It could also dial up pressure on the world’s largest pharmaceutical companies to prepare for a technological ar...

Read More

Why AI Is a Practical Solution for Pharma WHY AI IS A PRACTICAL SOLUTION FOR PHARMA

article

Jul 18, 2019

Artificial intelligence, or AI, is gaining more attention in the pharma space these days. At one time evoking images from futuristic science fiction, it now plays a significant role in smartphones, cars, search engines, and financial transactions. But what, exactly, is artificial intelligence? It is...

Read More

Need for Patient Engagement in Pharma Today NEED FOR PATIENT ENGAGEMENT IN PHARMA TODAY

article

Jul 18, 2019

Pharmaceutical and clinical industries are facing fierce demands from insurers, regulators, independent groups and consumers every day. In order to improve clinical trials and the drug discovery process, it is important to build better communication and links between all the stakeholders. This means...

Read More

What Pharma Companies Must Do Globally to Benefit From Canada’s Patent Term Extension Framework WHAT PHARMA COMPANIES MUST DO GLOBALLY TO BENEFIT FROM CANADA’S PATENT TERM EXTENSION FRAMEWORK

article

Jul 17, 2019

Canada implemented its patent term extension program, the Certificate of Supplementary Protection (CSP) framework, on September 21, 2017. The CSP regime is beneficial to qualifying pharmaceutical product developers because it can add up to two additional years of patent protection. Notably, CSP is n...

Read More

THE 7 PRINCIPLES OF PHARMA CONTENT THE 7 PRINCIPLES OF PHARMA CONTENT

article

Jul 17, 2019

In pharma, the sales process often starts with content, or a relationship may have started with some form of content. Great pharma content marketing follows a set of connected principles. Content marketing is the building of a narrative that looks to speak to target audiences, segments and personas ...

Read More

FDA Sent These Warning Letters To Pharma/Device Companies. FDA SENT THESE WARNING LETTERS TO PHARMA/DEVICE COMPANIES.

article

Jul 16, 2019

There were six warning letter postings during this week: three drug warning letters including one regarding Akorn’s site in Somerset, NJ that the company announced a few weeks ago, one to a device manufacturer, one to an IRB, and one to a compounding pharmacy.

Read More

The benefits of closed-loop marketing for pharma companies THE BENEFITS OF CLOSED-LOOP MARKETING FOR PHARMA COMPANIES

article

Jul 12, 2019

CLM has a huge impact on pharma companies, causing a major change in firm culture & ways of working, because of this new concept introduction. The idea is to create a virtuous circle between a target & a multi-channel digital marketing tool aimed for sales. CLM captures the Health Care Profe...

Read More

The End of an Era in Pharma THE END OF AN ERA IN PHARMA

article

Jul 12, 2019

National Health Commission has just released the first version of its monitoring catalogue for rational drug use. This is the first national-level policy aimed to curb “irrational drug use”; previous attempts have been trial runs at the provincial and municipal levels. The policy monitor...

Read More

Demystifying Multichannel Measurement Across the Pharma Product Lifecycle DEMYSTIFYING MULTICHANNEL MEASUREMENT ACROSS THE PHARMA PRODUCT LIFECYCLE

article

Jul 12, 2019

Pharmas are growing more assured in their use of digital channels and are increasingly taking a robust multichannel approach to healthcare professional engagement, moving away from their traditional focus on direct sales. Even so, many brands continue to miss the mark with their multichannel HCP eff...

Read More

How Does Pharma Learn to Speak Patient? The “Patient Voice” HOW DOES PHARMA LEARN TO SPEAK PATIENT? THE “PATIENT VOICE”

article

Jul 11, 2019

Before getting to the language of patients or “patient voice,” it is useful to understand that “we are not all patients.” Carolyn Thomas, writer and patient advocate, explains that, being a patient “sometime or other in life” is not the same thing as being a patie...

Read More

Real-World Evidence is What Pharma Needs Now to Help Cure Lung Cancer REAL-WORLD EVIDENCE IS WHAT PHARMA NEEDS NOW TO HELP CURE LUNG CANCER

article

Jul 11, 2019

Non-Small Cell Lung Cancer (NSCLC) is a designation that accounts for more than 80 percent of lung cancers diagnosed, and it has emerged as a new hotspot for investment by pharma manufacturers. Globally, the NSCLC therapeutics market is expected to rise to a valuation of US $15.1 billion by 2023, wi...

Read More

WITH PRESCRIPTION PRICES ON THE RISE, THIS STARTUP IS SHAKING UP PHARMA FROM THE INSIDE OUT WITH PRESCRIPTION PRICES ON THE RISE, THIS STARTUP IS SHAKING UP PHARMA FROM THE INSIDE OUT

article

Jul 10, 2019

In 2017, U.S. healthcare spending grew 3.9 percent, reaching $3.5 trillion. On average, that’s more than $10,000 per person. Smaller employers are having a hard time keeping up with rising costs, causing many to move to high-deductible plans that shift the cost burden onto the employee, says R...

Read More

Buried Treasure – Of a Sort BURIED TREASURE – OF A SORT

article

Jul 10, 2019

A former colleague was telling me the other day about some not-so-pleasant surprises that occurred when he was helping to clean out a lab that hadn’t had some cabinets opened in a while, and I think many readers will have had such experiences. Academic labs are particularly prone to Easter egg...

Read More

Sweet Almonds: One Amino Acid Did the Trick SWEET ALMONDS: ONE AMINO ACID DID THE TRICK

article

Jul 08, 2019

Well, I spent the holiday weekend here sending out pictures of food on my Twitter account, so I suppose it’s only fitting that I blog about a related topic today. But it also touches on metabolic enzymes, transcription factors, and death by cyanide, so there’s something for most everyone...

Read More

CMS Mandates Pharma to Disclose Drug Prices CMS MANDATES PHARMA TO DISCLOSE DRUG PRICES

article

Jul 04, 2019

If you are watching television in the United States, you are more than likely to see at least one drug commercial. These direct-to-consumer ads, as the industry knows them, offer brief testimonials of a drug’s effectiveness and safety, but typically leave out the drug’s price. As a bold ...

Read More

AMA Says Mature 12-Year-Olds Can Consent to Vaccination Without Parents AMA SAYS MATURE 12-YEAR-OLDS CAN CONSENT TO VACCINATION WITHOUT PARENTS

article

Jul 03, 2019

At the recently concluded annual meeting of the American Medical Association (AMA) in Chicago, AMA delegates adopted a doozy of a new policy. The powerful trade group agreed to develop model legislation that pressures state legislatures into allowing minors to "override refusenik parents on vac...

Read More

6 Reasons Why Advanced Analytics Is Essential In Pharma 6 REASONS WHY ADVANCED ANALYTICS IS ESSENTIAL IN PHARMA

article

Jun 30, 2019

It’s no secret that technology has had a major impact not only on our daily activities, but also on businesses in almost every industry. The pharma industry, in particular, has seen major changes throughout many operations due to the implementation of technology. Technology such as Artificial ...

Read More

AbbVie, Allergan, Ugh ABBVIE, ALLERGAN, UGH

article

Jun 26, 2019

News broke yesterday morning (first at the Wall Street Journal, I believe) that Abbvie has agreed to acquire Allergan. This is one of the larger pharma mergers of recent years, and regular readers of this site will have a pretty good idea of the sigh and roll of the eyes with which I greet it. I thi...

Read More

Acceleron Completes Target Enrollment in the PULSAR Phase 2 Trial of Sotatercept in Pulmonary Arterial Hypertension ACCELERON COMPLETES TARGET ENROLLMENT IN THE PULSAR PHASE 2 TRIAL OF SOTATERCEPT IN PULMONARY ARTERIAL HYPERTENSION

article

Jun 26, 2019

Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today it has completed target enrollment of patients with pulmonary arterial hypertension (PAH) in the PULSAR P...

Read More

The More the Merrier: High Doses of Lilly THE MORE THE MERRIER: HIGH DOSES OF LILLY'S TRULICITY SHOW SUPERIORITY IN REDUCING WEIGHT AND A1C

article

Jun 26, 2019

Eli Lilly’s type 2 diabetes drug Trulicity hit the mark in a late-stage trial that showed higher doses of the medication significantly reduced A1C from baseline compared to the once-per-week dose of Trulicity currently on the market. Trulicity (dulaglutide) is currently approved for type 2 dia...

Read More

Why Life Sciences Companies Should Be Aware Of Its Benefits WHY LIFE SCIENCES COMPANIES SHOULD BE AWARE OF ITS BENEFITS

article

Jun 21, 2019

Compliance with regulatory standards does not mean that life sciences companies should ignore ISO standards. We all know that implementing a management system or operational excellence program into a life science company’s workflow isn’t without its costs.

Read More

5 Ways Clinical Research Can Help You and Your Practice 5 WAYS CLINICAL RESEARCH CAN HELP YOU AND YOUR PRACTICE

article

Jun 21, 2019

Conducting clinical trials in one’s private practice—as opposed to hospitals or universities—has become more customary in clinical research. This trend is resulting in patients feeling more comfortable with participating in trials and is also providing physicians with unique benefi...

Read More

Bioanalysis at Alliance Pharma BIOANALYSIS AT ALLIANCE PHARMA

article

Jun 17, 2019

At Alliance Pharma, our large molecule mass spec group focuses primarily on two areas: protein characterization and low level quantitative bioanalysis. We take pride in our dedication to providing clients with all of the analytical information they need about their protein of interest, with agility ...

Read More

The many benefits of Continuous Manufacturing THE MANY BENEFITS OF CONTINUOUS MANUFACTURING

article

Jun 12, 2019

Continuous manufacturing is based on a number of requirements driven by the Pharmaceutical industry; quality, efficiency and speed to market being some of these. Bosch fulfilled these requirements when it released Xelum in 2017. The Xelum platform allows for faster development times and a reduced ri...

Read More

Understanding Chemistry of Biologics can Drive Innovation in Pharma UNDERSTANDING CHEMISTRY OF BIOLOGICS CAN DRIVE INNOVATION IN PHARMA

article

Jun 07, 2019

The consequences of consuming synthetic drugs (chemicals) are aplenty. The instances of pharmacovigilance keep surfacing, and they tarnish brand value which has long-lasting impact for a pharmaceutical company. As a result, most players developing drugs for complex diseases have ventured into discov...

Read More

Healthy lifestyle or Chronic Kidney Disease:The Choice is yours! HEALTHY LIFESTYLE OR CHRONIC KIDNEY DISEASE:THE CHOICE IS YOURS!

article

Jun 03, 2019

Chronic kidney disease (CKD) is a growing health problem with an estimated prevalence of around 11.5%.Individuals with CKD are at high risk for progressive kidney failure. End-stage kidney disease leads to considerable human and financial costs with a 5-year survival rate of less than 50%. There are...

Read More

Regulated cannabis industry would spur healthcare agenda REGULATED CANNABIS INDUSTRY WOULD SPUR HEALTHCARE AGENDA

article

Jun 03, 2019

Hemp, the non-psychoactive breed of cannabis, is the most versatile crop known to humans with thousands of uses in industry. Cannabis oil relieves chronic pain in debilitating illnesses such as cancer in both children and adults. Countries are beginning to consider decriminalising and legalising can...

Read More

Genocea Biosciences on Top GENOCEA BIOSCIENCES ON TOP

article

Jun 02, 2019

Despite the index’s dip, a number of NASDAQ biotech and pharma stocks still had notable share price increases last week. In particular, Genocea Biosciences (NASDAQ:GNCA) spiked on its announcement that the Journal of Clinical Oncology chose the company’s GEN-009 clinical results to be pr...

Read More

How US Sanctions Hinder Iranians’ Access to Medicine HOW US SANCTIONS HINDER IRANIANS’ ACCESS TO MEDICINE

article

May 31, 2019

The United States has over the past four decades imposed a wide range of economic sanctions to punish Iran for a number of undesired policies. While Trump administration officials continue to insist that food and medicine are exempt from US sanctions, and that sanctions do not hurt the Iranian peopl...

Read More

Cold Warriors Tanked Big Pharma Regulation COLD WARRIORS TANKED BIG PHARMA REGULATION

article

May 31, 2019

With prices climbing for lifesaving drugs like insulin, the regulation of Big Pharma is frequently in the news. Historian Dominique A. Tobbell writes that we’ve been having this debate since the 1950s. Back then, Senator Estes Kefauver, a Tennessee Democrat, became worried about the high price...

Read More

DIGITAL MARKETING STRATEGIES FOR PHARMA IN 2019 DIGITAL MARKETING STRATEGIES FOR PHARMA IN 2019

article

May 30, 2019

The digital marketing strategies for pharma companies tend to change pertaining to the region which means the same company needs to adopt different marketing strategies accordingly for its growth.

Read More

Why Pharma Franchise is a Boon for Small Pharmaceutical Companies? WHY PHARMA FRANCHISE IS A BOON FOR SMALL PHARMACEUTICAL COMPANIES?

article

May 30, 2019

Do you own a micro-sized or small company? If yes, then what business model do you think will be ideal when you aim at doing a profitable business?Ask anyone who is an expert in the niche, and you will get the answer, “pharma franchise business.” Statistics also prove the statement. Chec...

Read More

Schuh tv drug ads enough to make you sick. SCHUH TV DRUG ADS ENOUGH TO MAKE YOU SICK.

article

May 30, 2019

If everyone responded to TV drug ads’ prompts to “ask your doctor” or “check with your physician” about using the product, doctors likely would have no time to treat people. They’d be spending all their working hours answering questions. It used to be that the dog...

Read More

Matoke Pharma and antimicrobial resistance MATOKE PHARMA AND ANTIMICROBIAL RESISTANCE

article

May 29, 2019

Alan joined Matoke Pharma last year, having previous spent 35 years at Bayer, and he explained how that part of his career unfolded, from sales rep to antibiotics clinical research and then to global marketing and brand manager roles before ending with a series of senior management positions.

Read More

Big Pharma Emits More Greenhouse Gases Than the Automotive Industry BIG PHARMA EMITS MORE GREENHOUSE GASES THAN THE AUTOMOTIVE INDUSTRY

article

May 29, 2019

More than 200 companies represent the global pharmaceutical market, yet only 25 consistently reported their direct and indirect greenhouse gas emissions in the past five years. Of those, only 15 reported their emissions since 2012.One immediate and striking result is that the pharmaceutical sector i...

Read More

New Rules for Pharma in Life Sciences NEW RULES FOR PHARMA IN LIFE SCIENCES

article

May 29, 2019

Pharma must deliver much more than drugs on the way to a more consumer-oriented industry. Attention on continuous R&D innovation M&A activities often are only one element of pharma companies to maintain or strengthen their position in changing markets. Given the number of changes and challen...

Read More

Where Drugs Come From: A Comprehensive Look WHERE DRUGS COME FROM: A COMPREHENSIVE LOOK

article

May 28, 2019

On the roles of academia and industry in drug discovery. Which is a topic that refuses to go away. I am prepared to swear that before starting this blog I had no idea of how many people are convinced that the drug industry does little or no research, and that academic labs discover all the drugs. I ...

Read More

Historic trial to weigh big pharma HISTORIC TRIAL TO WEIGH BIG PHARMA'S ROLE IN OPIOID EPIDEMIC BEGINS

article

May 28, 2019

Hope for the opioid crisis: It's no secret that opioid deaths and overdoses are at crisis levels in the US. However, 2019 may bring new ways of fighting this epidemic. Every year, the Cleveland Clinic releases the most important medical advancements for the coming year, and at the top of its lis...

Read More

Could using old medication kill you? COULD USING OLD MEDICATION KILL YOU?

article

May 27, 2019

Winter has arrived and with it colds and flu. If you’re thinking of using meds that have been in the cabinet for months don’t do it. Spokesperson for pharmaceutical company Pharma Dynamics Nicole Jennings says keeping unused medication is not advised as it can lead to misuse and accident...

Read More

Partnering for Sublingual Success PARTNERING FOR SUBLINGUAL SUCCESS

article

May 24, 2019

Oral drug delivery has maintained a position of strength within the bio/pharma industry for a number of years, yet challenges associated with oral delivery, such as the harsh conditions of the gastrointestinal tract and enzymatic breakdown, have given rise to the advancement of alternative approache...

Read More

Looking beyond generic, Sun Pharma plans to develop its own medicines LOOKING BEYOND GENERIC, SUN PHARMA PLANS TO DEVELOP ITS OWN MEDICINES

article

May 23, 2019

You’d be hard-pressed to find someone who’s lost more during the recent upheaval in the generic drug business than Dilip Shanghvi: He forfeited $17 billion to be precise, plus the title of India’s richest man.After a four-year decline that erased 65 per cent from the value of Sun P...

Read More

More Hacks Inevitable in Pharma Industry, Cybersecurity Expert Sayss MORE HACKS INEVITABLE IN PHARMA INDUSTRY, CYBERSECURITY EXPERT SAYSS

article

May 22, 2019

Earlier this month, sophisticated cyber thieves hacked into the databases of Charles River Laboratories and compromised some client data. Hacks like this have happened before and they are bound to happen again – perhaps sooner, rather than later.Andrew Douthwaite, chief technology officer for ...

Read More

Zealand’s Severe Hypoglycemia Treatment Hits the Mark in Another Phase III Trial ZEALAND’S SEVERE HYPOGLYCEMIA TREATMENT HITS THE MARK IN ANOTHER PHASE III TRIAL

article

May 14, 2019

Denmark-based Zealand said dasiglucagon hit all primary and secondary endpoints in the late-stage trial assessing the safety and efficacy of the glucagon analog for severe hypoglycemia in diabetes patients. Zealand noted that dasiglucagon is a potential first-in-class therapy that is in development ...

Read More

Can pharma survive as data-driven therapy takes centre stage? CAN PHARMA SURVIVE AS DATA-DRIVEN THERAPY TAKES CENTRE STAGE?

article

May 08, 2019

Payment-by-outcomes and digital therapeutics (DTx) count among the serious challenges the pharma industry must negotiate in the coming years. They have the potential to change what healthcare industry reimburses. Rather than a drug alone, it will seek a package of drug, digital services and digital ...

Read More

GSK chases Trelegy asthma nod with mixed phase 3 results GSK CHASES TRELEGY ASTHMA NOD WITH MIXED PHASE 3 RESULTS

article

May 03, 2019

With generics attacking Advair, GlaxoSmithKline has talked up prospects for 3-in-1 respiratory med Trelegy. Now, the company has data in hand that could help it move into the asthma arena—though it's not all positive. Thursday, GSK released phase 3 trial data showing Trelegy had topped Bre...

Read More

From the Ashes of Scandal, Bausch Health Moves Ahead With Psoriasis Approval FROM THE ASHES OF SCANDAL, BAUSCH HEALTH MOVES AHEAD WITH PSORIASIS APPROVAL

article

Apr 26, 2019

Bausch Health, formerly known as Valeant Pharmaceuticals International, announced that the U.S. Food and Drug Administration (FDA) had approved its Duobrii (halobetasol propionate and tazoretene) Lotion for plaque psoriasis. The drug, developed by a Bausch division, Ortho Dermatologics, was rejected...

Read More

Targeted Proteomics: Benefits and Techniques TARGETED PROTEOMICS: BENEFITS AND TECHNIQUES

article

Apr 24, 2019

The proteome of the cell genome is more insightful compared to its transcriptome as proteins directly determine and alter cellular function. Post‐translational modification of existing proteins, increased abundance or allosterically modulated protein conformations have been tied to complex diseases,...

Read More

Big Pharma Cuts, Current and Coming BIG PHARMA CUTS, CURRENT AND COMING

article

Apr 22, 2019

Word came out just before the weekend (first at Endpoints) that GlaxoSmithKline is laying off R&D employees at both Stevenage (UK) and Upper Providence (US). Current leadership is re-organizing drug discovery efforts to put more emphasis on oncology, immunology and genetic-linked disease, and th...

Read More

Vetter’s Skokie Facility Expansion Nears Completion VETTER’S SKOKIE FACILITY EXPANSION NEARS COMPLETION

article

Apr 16, 2019

Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) announced today that a significant level of expansion activities are nearing completion at its US clinical manufacturing facility located at the Illinois Science & Technology Park in suburban Chicago. The ongoi...

Read More

Takeda adds reinforcement to its investor charm offensive TAKEDA ADDS REINFORCEMENT TO ITS INVESTOR CHARM OFFENSIVE

article

Apr 16, 2019

Financing and creating enduring confidence around a deal like Takeda’s $62 million purchase of Shire. To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest min...

Read More

Sugar Analysis Using Chromatography SUGAR ANALYSIS USING CHROMATOGRAPHY

article

Apr 15, 2019

The sensory and textural properties of foods can be attributed to monosaccharides, such as glucose, fructose, sucrose, and oligo and polysaccharides. The main difficulty while analyzing sugars is the variable isomeric forms that they can be present in. For example, glucose can be present in several ...

Read More

As superbugs threaten to create a global crisis, why are pharmaceutical companies shying away from antibiotics research. AS SUPERBUGS THREATEN TO CREATE A GLOBAL CRISIS, WHY ARE PHARMACEUTICAL COMPANIES SHYING AWAY FROM ANTIBIOTICS RESEARCH.

article

Apr 15, 2019

“China is a horror, India is a mega-horror,” says Alan Westwood, managing director of Matoke, a company hoping to develop a new form of antibiotic. “Russia is terrible. Don’t get sick in Greece either, the resistance rates are big, and in southern Europe generally.” Ant...

Read More

Origin: The pharma supply chain of the future ORIGIN: THE PHARMA SUPPLY CHAIN OF THE FUTURE

article

Apr 15, 2019

In an industry that evolves every day, having first mover advantage is a must for any pharmaceutical manufacturer looking to compete. Knowledge, infrastructure and foresight are key to remain efficient and agile as the industry faces numerous forces which are reshaping and dictating the direction of...

Read More

Big pharma: stop dodging taxes! BIG PHARMA: STOP DODGING TAXES!

article

Apr 12, 2019

A new report shows that the big pharma has enjoyed a whopping $7 billion tax cut in 2018 thanks to Trump’s new corporate-friendly tax rules. In just over a week’s time, Oxfam will be confronting Johnson & Johnson execs at the company’s big shareholder meeting -- and delivering ...

Read More

Improving Lung Cancer Survival and Alleviating Chemotherapy-induced Neutropenia IMPROVING LUNG CANCER SURVIVAL AND ALLEVIATING CHEMOTHERAPY-INDUCED NEUTROPENIA

article

Apr 11, 2019

Neutropenia is a common, often severe adverse effect experienced by cancer patients who are undergoing chemotherapy treatment. We recently spoke with Dr Lan Huang, CEO at BeyondSpring, a clinical-stage biopharmaceutical company to learn more about the company’s efforts to develop innovative im...

Read More

Tetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer TETRA BIO-PHARMA AND OVENSA WILL ENGAGE IN A COLLABORATION TO TACKLE BRAIN CANCER

article

Apr 11, 2019

OTTAWA, April 11, 2019 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V: TBP) (OTCQB: TBPMF), today announced that it has entered into a collaboration agreement with Ovensa Inc. (“Ovensa”) to evaluate TRIOZAN™, a proprietary n...

Read More

Enesi Pharma and University of Oxford collaborate to target plague with a novel ImplaVax®-enabled adenovirus-based solid dose vaccine ENESI PHARMA AND UNIVERSITY OF OXFORD COLLABORATE TO TARGET PLAGUE WITH A NOVEL IMPLAVAX®-ENABLED ADENOVIRUS-BASED SOLID DOSE VACCINE

article

Apr 10, 2019

Enesi Pharma (“Enesi”), an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products and scientists at the world-renowned Oxford Vaccine Group (“OVG”) at the University of Oxford, announce they have entered into a collaborative agr...

Read More

4 pharma companies saved $7 billion from GOP tax law 4 PHARMA COMPANIES SAVED $7 BILLION FROM GOP TAX LAW

article

Apr 09, 2019

Four pharmaceutical companies — Johnson & Johnson, Pfizer, Merck and Abbott Laboratories — collectively kept $7 billion in tax savings in 2018 due to Republicans' 2017 corporate tax overhaul, according to a new Oxfam report. The bottom line: Oxfam's results mirror our reporti...

Read More

How a self-learning Ontology benefits Pharma and Life Sciences? HOW A SELF-LEARNING ONTOLOGY BENEFITS PHARMA AND LIFE SCIENCES?

article

Apr 03, 2019

Every domain has its own language. The same word used in different domains can have totally different meanings. In fact, the same word can mean two separate things for different subdomains, eg. in science, hedgehog is both animal and protein. Moreover, domain language is dominated by abbreviations a...

Read More

When It Comes to Hiring PhDs, Private Sector and Academia Are About Even WHEN IT COMES TO HIRING PHDS, PRIVATE SECTOR AND ACADEMIA ARE ABOUT EVEN

article

Mar 20, 2019

For years, the biggest employers of science and engineering PhDs have been academic institutions. For example, according to the U.S. National Science Foundation (NSF)’s biennial Survey of Doctoral Recipients, academia employed 11 percent more PhDs than the private sector in 1997. The NSF Surve...

Read More

Pharma M&A Is on Fire and AI Is the Gasoline PHARMA M&A IS ON FIRE AND AI IS THE GASOLINE

article

Jun 17, 2012

A perfect storm is brewing in pharma M&A. Reduced R&D productivity, comparative advantages of large pharma companies, and the Trump Administration’s tax cuts make M&A more attractive than usual for an already acquisitive industry. To navigate these waters, pharma giants must embrac...

Read More



SPOTLIGHT

We work with pharma companies across the globe from North America to Europe, the Far East & across Asia, providing outsourced QC support to the drug development pipeline & companion diagnostics.

RESOURCES